Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Medicina (Kaunas) ; 59(3)2023 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-36984497

RESUMO

Background and Objectives: Neutrophil infiltration is an established signature of Non-Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH). The most abundant neutrophilic peptide, alpha-defensin, is considered a new evolving risk factor in the inflammatory milieu, intimately involved in lipid mobilization. Our objective is to assess for potential association between alpha-defensin immunostains and NAFLD severity. Materials and Methods: We retrospectively investigated the liver biopsies of NAFLD/NASH patients, obtained at Hillel Yaffe Medical center between the years 2012 and 2016. Patients' characteristics were recorded, including relevant blood tests at the time of biopsy. Each biopsy was semi-quantitatively scored using NAFLD Activity Score (NAS) and NASH fibrosis stage. The biopsies were immunostained for alpha-defensin. The precipitation of alpha-defensin was correlated to NAS and fibrosis. Results: A total of 80 biopsies were evaluated: male ratio 53.2%, mean age 44.9 ± 13.2 years, 54 had fibrosis grades 0-2, and 26 were grade 3-4. Conventional metabolic risk factors were more frequent in the high-grade fibrosis group. Immunostaining for alpha-defensin disclosed higher intensity (a.u.) in grade 3-4 fibrosis relative to grades 0-2, 25% vs. 6.5%, p < 0.05, respectively. Moreover, alpha-defensin staining was nicely co-localized with fibrosis. Conclusions: In our group of NASH/NAFLD patients, higher metabolic risk profile was associated with higher fibrosis grade. Immunostaining for alpha-defensin showed patchy intense staining concordant with high fibrosis, nicely co-localized with histological fibrosis. Whether alpha-defensin is a profibrotic risk factor or merely risk marker for fibrosis must be clarified in future studies.


Assuntos
Hepatopatia Gordurosa não Alcoólica , alfa-Defensinas , Humanos , Masculino , Adulto , Pessoa de Meia-Idade , Fígado/patologia , Estudos Retrospectivos , alfa-Defensinas/metabolismo , Neutrófilos , Cirrose Hepática/complicações , Fibrose , Biópsia
2.
Pediatr Emerg Care ; 29(6): 756-7, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23736073

RESUMO

Valproic acid intoxication may be associated with cerebral, cardiovascular, respiratory, gastrointestinal, and hematologic complications. We report a case of a 7-year-old girl, epilepsy-treated chronically with valproic acid, sulthiame, and clonazepam, who presented to the emergency room because of a global deterioration during the preceding 2 months, including poorer feeding and worsened general responsiveness. The girl was later diagnosed to have chronic valproic acid intoxication.


Assuntos
Anticonvulsivantes/intoxicação , Overdose de Drogas/etiologia , Letargia/induzido quimicamente , Erros de Medicação , Ácido Valproico/intoxicação , Anticonvulsivantes/administração & dosagem , Paralisia Cerebral/complicações , Química Farmacêutica , Criança , Doença Crônica , Deficiências do Desenvolvimento/complicações , Relação Dose-Resposta a Droga , Epilepsia/complicações , Epilepsia/tratamento farmacológico , Feminino , Humanos , Quadriplegia/complicações , Trombocitopenia/induzido quimicamente , Ácido Valproico/administração & dosagem
3.
J Clin Med ; 12(20)2023 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-37892652

RESUMO

Background: It is prudent to develop biomarkers that enhance the differentiation between viral and bacterial infection in order to support expeditious and judicious antimicrobial implementation in emergency department admissions. Human neutrophilic peptides 1-3 (HNP1-3) are the major neutrophilic peptides with potent antimicrobial activity. Methods: We tested the performance of the plasma HNP1-3 test in a prospective observational cohort of children admitted to the emergency department for fever. We validated this test with traditionally used biomarkers and final diagnoses. An expert panel reviewed the patient's data and gave a final diagnosis. The final diagnosis was classified as definite, probable, or possible. Results: A total of 111 children (98 with fever and 13 control) were recruited: 55% male, mean age 6.3 years. Plasma HNP1-3 levels were higher with bacterial infections: 10,428 (5789-14,866) vs. 7352 (3762-10,672) pg/mL, p = 0.007. HNP1-3 were negatively correlated with age: r = -0.207, p = 0.029. Of the different categorical variables tested, only c-reactive protein (CRP) (≥42.3 mg/dL), neutrophil count (≥10.2), and age (odds ratio = 1.185, p = 0.013 and 95%CI = 1.037-1.354) had significant diagnostic capability for bacterial disease prediction. Conclusions: Due to its low diagnostic value in febrile patients, the HNP1-3 value is not currently recommended to support pathogen differentiation in children in an emergency setting. Further studies are needed to support its clinical use.

4.
Harefuah ; 151(6): 330-1, 380, 2012 Jun.
Artigo em Hebraico | MEDLINE | ID: mdl-22991859

RESUMO

We report on a girl who was diagnosed with classical hereditary xanthinuria due to an incidental finding of extremely low Levels of uric acid in the blood. The girl is compLetely asymptomatic. Hereditary xanthinuria is a rare autosomal recessive disease that usually causes early urolithiasis but may cause rheumatoid arthritis-like disease and even be associated with defects in the formation of bone, hair and teeth. In Israel it has mostly been described in patients of Bedouin origin. Throughout the world, only about 150 cases have been described; about two thirds of these patients were asymptomatic. Since the clinical presentation and age of symptom appearance are diverse, the case raises questions as to the required follow-up of these patients and as to whether a low oxalate diet should be initiated.


Assuntos
Dietoterapia/métodos , Erros Inatos do Metabolismo da Purina-Pirimidina , Conduta Expectante/métodos , Xantina , Árabes , Doenças Assintomáticas , Pré-Escolar , Gerenciamento Clínico , Feminino , Humanos , Achados Incidentais , Israel/epidemiologia , Monitorização Fisiológica/métodos , Oxalatos/metabolismo , Erros Inatos do Metabolismo da Purina-Pirimidina/complicações , Erros Inatos do Metabolismo da Purina-Pirimidina/etnologia , Erros Inatos do Metabolismo da Purina-Pirimidina/metabolismo , Erros Inatos do Metabolismo da Purina-Pirimidina/fisiopatologia , Erros Inatos do Metabolismo da Purina-Pirimidina/terapia , Resultado do Tratamento , Ácido Úrico/sangue , Ácido Úrico/urina , Xantina/metabolismo , Xantina/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA